The gut remembers: the long-lasting effect of medication use on the gut microbiome

Pamela Ferretti1

  • 1Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, Illinois, USA.

Msystems
|September 22, 2025
PubMed

Insights

Many common medications, including antibiotics and antidepressants, can alter the gut microbiome for years. This study highlights medication history as a crucial factor in microbiome research.

Area of Science:

  • Microbiology
  • Pharmacology
  • Genomics

Background:

  • Medications like antibiotics can impact gut microbiome composition.
  • The long-term effects of drug-induced microbiome alterations are not well understood.

Purpose of the Study:

  • To investigate the persistent effects of various medications on the gut microbiome composition.
  • To assess the utility of combining electronic health records (EHR) with metagenomic data.

Main Methods:

  • Utilized EHR and stool metagenomic data from 2,509 individuals.
  • Analyzed medication use up to five years prior to sample collection.
  • Examined the association between 186 different drugs and gut microbiome profiles.

Main Results:

  • Nearly half of the tested drugs demonstrated long-term effects on the gut microbiome.
  • Antibiotics, beta-blockers, benzodiazepines, proton-pump inhibitors, and antidepressants showed persistent microbiome changes.
  • Repeated medication use led to additive effects on the microbiome.

Conclusions:

  • Past medication use is a significant confounding factor in microbiome studies.
  • Combining EHR and microbiome data is valuable for understanding drug-induced microbiome changes.
  • Long-term microbiome alterations from medications necessitate careful consideration in research and clinical practice.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
425
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
621
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
726
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
507
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.0K